Results summary | View all lists in L2L MDB | View all genes in V03A.profile.ud50 |
Down-regulated following treatment with Et-743 at any timepoint in at least 8 of 11 sarcoma cell lines enrichment: 2.64-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
209048_S_AT | ZMYND8 | zinc finger, MYND-type containing 8 | |||||||||||
216275_AT | BUB1 | G | P | BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) | |||||||||
211551_AT | EGFR | G | D | X | P | C | S | epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | |||||
202535_AT | FADD | G | S | Fas (TNFRSF6)-associated via death domain | |||||||||
218251_AT | MID1IP1 | P | MID1 interacting protein 1 (gastrulation specific G12 homolog (zebrafish)) | ||||||||||
200768_S_AT | MAT2A | methionine adenosyltransferase II, alpha |